← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2018Last known activity
Sep 30, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 2 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT05190094Study directorPhase 2Sep 30, 2022
- NCT05190094Lead sponsorPhase 2Sep 30, 2022
- NCT05190094OfficialPhase 2Sep 30, 2022
- NCT03447132Study chairPhase 3Jan 1, 2018
- NCT03447132Lead sponsorPhase 3Jan 1, 2018
Details
- Last known activity
- Sep 30, 2022